What is NDC 0143-9326?

0143-9326 is the product NDC for Milrinone Lactate, Milrinone lactate 1 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Milrinone Lactate?

25 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Milrinone Lactate NDC 0143-9326 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9326Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9326Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9326-10	0014393261000143932610	10 VIAL in 1 CARTON (0143-9326-10) / 20 mL in 1 VIAL (0143-9326-01)Marketed from Dec 3, 2010

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Milrinone Lactate
Generic name (nonproprietary): milrinone lactate
Active ingredients: Milrinone lactate — 1 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077966
Marketing start: Dec 3, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Phosphodiesterase 3 Inhibitors (Mechanism)
Identifiers: Product ID 0143-9326_181d0496-395b-420b-ae94-99921949fc16SPL ID 181d0496-395b-420b-ae94-99921949fc16SPL set ID bb7500f8-dbfd-4c8a-ac2e-5533609c3970RxCUI 1791859UNII 9K8XR81MO8
Pharmacologic class: Phosphodiesterase 3 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143932610 followed by a unit qualifier and the quantity

Package 00143-9326-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2018.

Indications (excerpt from the label)

INDICATIONS AND USAGE Milrinone lactate injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. Patients receiving milrinone should be observed closely with appropriate electrocardiographic equipment. The facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available. The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. There is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0143-9326

What is NDC 0143-9326?: 0143-9326 is the product NDC for Milrinone Lactate, Milrinone lactate 1 mg/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Milrinone Lactate.
What is the active ingredient?: Milrinone lactate.
Who is the labeler?: Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Milrinone Lactate?: 25 other product NDCs are listed under this name. See all Milrinone Lactate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Milrinone Lactate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Shandong New Time Pharmaceutical Co., Ltd.	42677-338	42677-0338-0142677-0338-10
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-120	65145-0120-10
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-121	65145-0121-10
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-122	65145-0122-01
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Mullan Pharmaceutical Inc.	83301-0016	83301-0016-02
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Mullan Pharmaceutical Inc.	83301-0017	83301-0017-02
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Mullan Pharmaceutical Inc.	83301-0018	83301-0018-01
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Armas Pharmaceuticals Inc.	72485-501	72485-0501-10
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Armas Pharmaceuticals Inc.	72485-502	72485-0502-10
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Armas Pharmaceuticals Inc.	72485-503	72485-0503-01

All 26 Milrinone Lactate NDCs

Other NDCs under ANDA 077966

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077966
Product	Strength	Form · route	Labeler	Product NDC
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9373
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9374
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9708
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9709
Milrinone Lactate	Milrinone lactate 1 mg/mL	Injection, SolutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9710